tricalcium phosphate has been researched along with amifostine anhydrous in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 4 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Liu, M; Liu, YN; Ren, PY | 2 |
| Liu, J; Liu, M; Liu, Y; Ren, P | 1 |
| Chen, JY; Chen, SY; Chiang, CS; Chiang, MY; Huang, WC; Li, WM; Su, CW | 1 |
4 other study(ies) available for tricalcium phosphate and amifostine anhydrous
| Article | Year |
|---|---|
[Physicochemical and sustained drug release properties of calcium phosphate cement/amifostine/cisplatin complex and its effect in repairing bone defect due to tumor resection in rabbits].
Topics: Amifostine; Animals; Bone Cements; Calcium Phosphates; Cisplatin; Delayed-Action Preparations; Female; Femoral Neoplasms; Implants, Experimental; Male; Osteosarcoma; Porosity; Rabbits | 2010 |
[In vitro study on physical and chemical properities of calcium phosphate cement/amifostine complex and on vitality of cultured cells].
Topics: Amifostine; Bone Cements; Calcium Phosphates; Cell Line, Tumor; Cell Survival; Cells, Cultured; Chemical Phenomena; Endothelial Cells; Humans; Osteosarcoma | 2010 |
[Drug delivery of CPC/amifostine/cisplatin complex in vitro and its ability in repairing bone defect and eliminating tumor in vivo].
Topics: Amifostine; Animals; Bone Cements; Bone Neoplasms; Calcium Phosphates; Cisplatin; Drug Delivery Systems; Female; Femur; Implants, Experimental; Male; Osteosarcoma; Rabbits; Rats; Rats, Sprague-Dawley | 2010 |
Amifostine-conjugated pH-sensitive calcium phosphate-covered magnetic-amphiphilic gelatin nanoparticles for controlled intracellular dual drug release for dual-targeting in HER-2-overexpressing breast cancer.
Topics: Amifostine; Animals; Calcium Phosphates; Curcumin; Delayed-Action Preparations; Doxorubicin; Female; Gelatin; Humans; Hydrogen-Ion Concentration; Magnetics; MCF-7 Cells; Mice; Nanoparticles; Receptor, ErbB-2 | 2015 |